We are live on ! Find out more
LCS

Levin Capital Strategies Portfolio holdings

AUM $1.32B
1-Year Est. Return 28.11%
This Fund
S&P 500
This Quarter Est. Return
+5.69%
1 Year Est. Return
+28.11%
3 Year Est. Return
+79.27%
5 Year Est. Return
+107.45%
10 Year Est. Return
+287.53%
AUM
$5.82B
AUM Growth
+$5.82B
Cap. Flow
-$135M
Cap. Flow %
-2.32%
Top 10 Hldgs %
38.85%
Holding
370
New
37
Increased
64
Reduced
141
Closed
67

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$98.8M
2
PRMW
Primo Water Corporation
PRMW
+$73.5M
3
ATH
Athene Holding Ltd. Class A Common Shares
ATH
+$66.3M
4
SUM
Summit Materials, Inc. Class A Common Stock
SUM
+$62.1M
5
MCD icon
McDonald's
MCD
+$58.1M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$162M
2
GLW icon
Corning
GLW
+$122M
3
PF
Pinnacle Foods, Inc.
PF
+$67.6M
4
MPG
Metaldyne Performance Group Inc.
MPG
+$59.7M
5
AMAT icon
Applied Materials
AMAT
+$57.5M

Sector Composition

Rank Sector Weight
1 Financials 22.67%
2 Technology 15.52%
3 Healthcare 14.22%
4 Consumer Staples 9.96%
5 Materials 9.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
C icon
1
Citigroup
C
$215B
$348M 5.97%
5,848,210
-700,350
-11% -$37.8M
PFE icon
2
Pfizer
PFE
$143B
$270M 4.64%
8,761,460
+500,021
+6% +$15.3M
NOK icon
3
Nokia
NOK
$48B
$248M 4.25%
51,467,474
+11,259,027
+28% +$53.1M
OXY icon
4
Occidental Petroleum
OXY
$55.5B
$235M 4.03%
3,297,622
+505,652
+18% +$35.9M
PRMW
5
DELISTED
Primo Water Corporation
PRMW
$232M 3.99%
20,501,883
+5,929,414
+41% +$73.5M
INTC icon
6
Intel
INTC
$430B
$231M 3.96%
6,362,177
+1,190,677
+23% +$42.6M
DD icon
7
DuPont de Nemours
DD
$18.8B
$201M 3.45%
1,386,680
+104,854
+8% +$14.6M
ETN icon
8
Eaton
ETN
$142B
$183M 3.15%
2,731,856
+384,909
+16% +$25.3M
CB icon
9
Chubb
CB
$141B
$159M 2.73%
1,204,098
-194,672
-14% -$24.8M
JPM icon
10
JPMorgan Chase
JPM
$923B
$156M 2.68%
1,804,893
-371,141
-17% -$28.3M
PF
11
DELISTED
Pinnacle Foods, Inc.
PF
$153M 2.63%
2,862,334
-1,332,398
-32% -$67.6M
AAPL icon
12
Apple
AAPL
$5.03T
$152M 2.61%
5,252,008
-72,532
-1% -$2.06M
MS icon
13
Morgan Stanley
MS
$323B
$148M 2.55%
3,510,896
-118,484
-3% -$4.48M
MON
14
DELISTED
Monsanto Co
MON
$142M 2.43%
1,347,396
-65,765
-5% -$6.74M
TGT icon
15
Target
TGT
$66.8B
$133M 2.28%
1,840,654
+37,889
+2% +$2.74M
HBAN icon
16
Huntington Bancshares
HBAN
$34.2B
$127M 2.19%
9,623,900
-44,361
-0.5% -$517K
HES
17
DELISTED
Hess
HES
$120M 2.07%
1,931,338
+391,158
+25% +$21.4M
MCD icon
18
McDonald's
MCD
$193B
$119M 2.05%
978,968
+495,256
+102% +$58.1M
DD
19
DELISTED
Du Pont De Nemours E I
DD
$117M 2%
1,588,120
-446
-0% -$31.7K
TMO icon
20
Thermo Fisher Scientific
TMO
$213B
$103M 1.77%
731,994
+670,206
+1,085% +$98.8M
CVA
21
DELISTED
Covanta Holding Corporation
CVA
$97.8M 1.68%
6,272,339
-79,096
-1% -$1.18M
APC
22
DELISTED
Anadarko Petroleum
APC
$83.7M 1.44%
1,200,652
-9,966
-0.8% -$648K
CI icon
23
Cigna
CI
$78.5B
$80.3M 1.38%
601,673
-327,918
-35% -$42.9M
SYF icon
24
Synchrony
SYF
$24.6B
$73.3M 1.26%
2,022,168
-1,733,919
-46% -$55.4M
AMAT icon
25
Applied Materials
AMAT
$361B
$70.7M 1.21%
2,190,715
-1,889,130
-46% -$57.5M
1
2 3 4 5

Similar funds

MDSL
M.D. Sass LLC New York $1.32B AUM 16.01% 1-Year Est. Return
CP
Cumberland Partners Toronto, Ontario, Canada $1.32B AUM 27.83% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
IEFM
IQ EQ Fund Management Dublin 2, Ireland $1.32B AUM 31.52% 1-Year Est. Return
GSEP
Golden State Equity Partners South Coast Metro, California $1.32B AUM 23.87% 1-Year Est. Return
MCM
Mill Capital Management Concord, North Carolina $1.31B AUM 17.4% 1-Year Est. Return
B
BloombergSen Toronto, Ontario, Canada $1.31B AUM 8.32% 1-Year Est. Return
HCM
Hilton Capital Management Garden City, New York $1.32B AUM 15.59% 1-Year Est. Return

Levin Capital Strategies's Q4 2016 Portfolio in Review

As of Q4 2016, Levin Capital Strategies held 370 positions worth $5.82B, up 85,528% from $6.8M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Levin Capital Strategies's Q4 2016 filing shows 37 new, 64 increased, 141 reduced and 67 closed positions. Its largest new stake was Athene Holding Ltd. Class A Common Shares: 1,433,996 shares worth $68.8M. The largest sale was Gilead Sciences, an estimated $162M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, down from 31% a quarter earlier, followed by Technology and Healthcare.

  • Levin Capital Strategies's largest Q4 2016 buy was Athene Holding Ltd. Class A Common Shares: 1,433,996 shares worth $68.8M.
  • Levin Capital Strategies added most to Thermo Fisher Scientific in Q4 2016, an estimated $98.8M increase.
  • Levin Capital Strategies's biggest Q4 2016 reduction was Gilead Sciences, cutting an estimated $162M.
  • Levin Capital Strategies fully exited Univar Solutions Inc. in Q4 2016, selling an estimated $25.1K.
  • Levin Capital Strategies's ten largest holdings make up 39% of its $5.82B portfolio in Q4 2016.
  • Levin Capital Strategies opened 37 new positions and closed 67 in Q4 2016.
  • Levin Capital Strategies's portfolio value rose 85,528% quarter-over-quarter to $5.82B.

Based on Levin Capital Strategies's 13F filing for Q4 2016, filed 14 Feb 2017.